Brisbane clinic to begin trials on COVID drug

Tell a friend about this post
A Brisbane clinic is set to begin human trials on a drug that’s exhibited a strong anti-viral effect against COVID-19.
Niclosamide has been used as an anti-parasitic treatment since it was developed in 1958 and sold worldwide under the name Yomesan.
The drug works by preventing a virus from invading host cells, and thereby suppresses its proliferation.
Tell a friend about this post
READ ALSO  Report: Vaccine storage demands could leave 3B people in virus cold


Leave a Reply

Your email address will not be published. Required fields are marked *

You cannot copy content of this page